TipRanks
Go Ultimate55% OFF

Aspire Biopharma Holdings (ASBP) Income Statement

Aspire Biopharma Holdings Income Statement

Last quarter (Q2 2026), Aspire Biopharma Holdings's total revenue was $63.10K. In Q2, Aspire Biopharma Holdings's net income was $-1.27M. See Aspire Biopharma Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 6.20K$ 0.00$ 0.00$ 0.00$ 0.00
$ -116.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 19.35M$ 1.21M$ 1.34M$ 976.35K$ 25.48K
Depreciation and Amortization$ 8.02M$ 0.00$ 1.34M$ 0.00$ 27.79K
$ -11.33M$ -1.21M$ 5.81M$ -976.35K$ 2.32K
$ -19.35M$ -1.21M$ -1.34M$ -976.35K$ -25.48K
$ -5.13M$ -97.99K$ 5.80M$ 4.32M$ 5.00
$ -24.48M$ -1.31M$ 4.46M$ 3.34M$ -25.48K
$ -24.48M$ -1.31M$ 4.46M$ 3.34M$ -25.48K
Per Share Metrics
Basic EPS$ -16.38$ -34.17$ 9.31$ 3.72$ -0.04
Diluted EPS$ -16.38$ -34.17$ 9.31$ 3.72$ -0.04
Weighted Average Shares Outstanding1.49M38.34K479.48K898.44K682.81K
Weighted Average Shares Outstanding (Diluted)1.49M38.34K479.48K898.44K682.81K

Currency in USD

Aspire Biopharma Holdings Earnings and Revenue History

-30M-15M015M-394727 %-394726 %-394725 %-394724 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin